psilocin
Megjelenés
| Clinical data | |
|---|---|
| Other names | Psilocine; Psilocyn; Psilotsin; 4-Hydroxy-N,N-dimethyltryptamine; 4-Hydroxy-DMT; 4-Hydroxy-N,N-DMT; 4-HO-DMT; 4-OH-DMT; PSOH; PAL-153; PAL153; CX-59; CX59 |
| Routes of administration | By mouth, intravenous |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin receptor agonist |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Oral psilocybin: 52.7 ± 20.4% (as psilocin) |
| Metabolism | Liver, other tissues: |
| Metabolites | • Psilocin-O-glucuronide |
| Elimination half-life | Oral psilocybin: 2.3–3 hours (as psilocin) |
| Excretion | Urine (mainly as psilocin-O-glucuronide, 2–4% unchanged) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H16N2O |
| Molar mass | 204.273 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 173 to 176 °C (343 to 349 °F) |
| |
| |
| (verify) | |
Főnév
psilocin (tsz. psilocins)